MichaelWayneBoyerMD
Pediatric Hematology & Oncology • Salt Lake City, UTDirector Blood and Marrow Transplant University of Utah
Dr. Boyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 N Medical Dr
BMT
Salt Lake City, UT 84113Phone+1 801-585-3229Fax+1 801-585-3432
Education & Training
University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1991 - 1995- University of MinnesotaResidency, Pediatrics, 1987 - 1990
Indiana University School of MedicineClass of 1987
Certifications & Licensure
UT State Medical License 2006 - 2026
OH State Medical License 2000 - 2007
GA State Medical License 1995 - 2001
MN State Medical License 1991 - 1996- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
- Phase I/II Study of Treg/Tcon Addback to Partially Matched Related Donor Stem Cells With Myeloablative Conditioning and Post-transplant Cyclophosphamide for High Risk Hematologic Malignancies Start of enrollment: 2013 Jul 12
- Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients Start of enrollment: 2015 Apr 08
Publications & Presentations
PubMed
- 4092 citationsPembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung CancerLeena Gandhi, Delvys Rodriguez-Abreu, Shirish M. Gadgeel, Emilio Esteban, Enriqueta Felip
The New England Journal of Medicine. 2018-04-16 - 228 citationsPemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNO...Delvys Rodriguez-Abreu, Steven Francis Powell, Maximilian Hochmair, Shirish M. Gadgeel, Emilio Esteban
Annals of Oncology. 2021-07-01 - 2222 citationsPhase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaNicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski, Claude Denham, E. Kaukel
Journal of Clinical Oncology. 2003-07-15
Journal Articles
- Genetic Mechanisms of Target Antigen Loss in CAR19 Therapy of Acute Lymphoblastic LeukemiaJohn E Levine, Muna Qayed, Stephan A Grupp, Eneida R Nemecek, Stella M Davies, Michael R Verneris, Michael Boyer, Jeffrey A Engelman, Nature
- Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic LeukemiaMichael W Boyer, Bruce L Levine, Carl H June, Theodore W Laetsch, Clinical Cancer Research
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
